November 15, 2023
London, UK
November 13, 2023
Novartis 10th annual ESG investor event
November 08, 2023
Miami, FL, USA
October 24, 2023
Basel, Switzerland
Watch the webcast
October 10, 2023
September 15, 2023
Basel, Switzerland
Sep 13, 2023
London, UK
Sep 12, 2023
New York, USA
September 06, 2023
Boston, USA
June 29, 2023
Bordeaux, France
June 22, 2023
London, UK
June 21, 2023
London, UK
June 12, 2023
Dana Point, USA
June 04, 2023
Chicago, USA
May 09, 2023
Las Vegas, USA
April 26, 2023
Today Novartis has published updated 2022 quarterly and full year segment financials reflecting transfers of Sandoz biotechnology manufacturing services to other companies’ activities and the Coartem® brand from Sandoz to the Innovative Medicines Division, which were effective as of January 1, 2023. The 2022 updated segment financial reporting is provided in accordance with requirements of IFRS, and to aid comparability of 2023 quarterly and full year results for the segments and Corporate.
April 25, 2023
Basel, Switzerland
Media release:
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.3 MB)
Condensed financial report (PDF 0.3 MB)
Download the interactive presentation (PDF 3.4 MB)
Download the podcast (MP3 34 MB)
Read the presentation transcript
Novartis Q1 2023 Impact and Sustainability Update (PDF 1.9 MB)
March 14, 2023
Miami, FL
March 07, 2023
Basel, Switzerland
March 07, 2023
Boston, MA
March 01, 2023
London, UK
February 21, 2023
Virtual
February 14, 2023
Virtual
February 08, 2023
Virtual
January 09, 2023
San Francisco, USA
Download the presentation (PDF 2.7 MB)
Download the podcast (MP3 18 MB)